Institutional Ownership
Liminatus Pharma Inc.
CUSIP 53271X116*W EXP 04/30/203LIMNWQ1 2026
Institutional Holders
21
13F filers
Shares Held
1.59M
Aggregate institutional
Institutional Value
$71.6K
Q1 2026
Net New Holders
-3
0 new · 3 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions0
Increased1
Decreased3
Sold out3
Institutional Holders
21 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Aristeia Capital, L.L.C. | 319.5K | $15.7K | 0 | Held |
| 2 | Linden Advisors LP | 268.2K | $13.1K | 0 | Held |
| 3 | Saba Capital Management, L.P. | 233.8K | $11.5K | 0 | Held |
| 4 | Polar Asset Management Partners Inc. | 122.7K | $6.0K | 0 | Held |
| 5 | Moore Capital Management, LP | 125.0K | $5.0K | 0 | Held |
| 6 | Mmcap International Inc. Spc | 111.7K | $4.5K | 0 | Held |
| 7 | D. E. Shaw & Co., Inc. | 83.4K | $3.3K | 0 | Held |
| 8 | Blue Owl Capital Holdings LP | 50.0K | $2.0K | 0 | Held |
| 9 | Periscope Capital Inc. | 47.5K | $1.9K | 0 | Held |
| 10 | Wolverine Asset Management LLC | 39.4K | $1.6K | −23.4K | Reduced |
11 more institutional holders on Premium
See every fund holding Liminatus Pharma Inc., with full quarter-over-quarter share changes.
Unlock all holders